Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
That is what we keep hearing, but we can't even seem to get clinical trial going.
I am buying all the shares :) Crap, i have to buy down my average. I started a position at .80 after CEO said this this is worth 2.10.
The last time I called Dianne, there was suppose to be a 2 weeks delay, That was six weeks ago.
Trial that was suppose to start mid March still have not started, starting to think if there is any inherent issue with clinical data from Carmago.
Looks like we are headed for another RED day. Whatever happened to the trials due to start in March, April, May - June, July, August, September? I haven't heard anything more on that after a 3 week delay which has since passed. But NH does what he says he is going to do unless when it is convenient not to do it. He also does what he has not said he is going to do, i.e., 40M dollar LPC deal heaping another 150 million or so shares on to the dilution pool. Massive dilution building up! Get you shares now before they get cheaper.
There is no such thing as Fast track for Opioid release pain killers, Fast Track are only for drugs that treats rare disease and currently has no treatment or ineffective treatment. The best that Elite can hope for is Priority review. Management is very confident that once they send in their NDA, they will get Priority review because of the political climate surrounding Non-Art/ADT Opioid released pain killers.
All these are done in house and not verified by the SEC or anyone out side Elite. You do your DD sir!
People buy in to the confidence and experience of Nasrat and the track record of the last 2 years with ELITE. If Nasrat hype this stock with faulty evaluation, one must ask if stock holder interest is his priority. Look at Gale and ICLD, we all have to be concern. And please, i have upper six figures holding in this stock, we all did our DD when investing with that much money, don't assume that you are the only one that does his DD when it comes to investing.
Releasing the names of the firm would allow appropriate accountability and transparency.
That is true that no one forced me to buy but having a a questionable evaluation to hype the stock is unethical to say the least.
It is not irrelevant, If we know that their actions are not up front questionable, we can buy or sell with certain PR that comes out and not get caught up painful down slide.
What material impact does it have on the shareholders? Are you kidding me? Prices have drop 70 percent and you are asking me that?
If it is a legitimate company, they should have no problem releasing their names. " Their phone would ring off the hook" answer is BS. you know it and i know it. If they are ultimately looking out for investors, releasing the the name of the firm that did the evaluation would only bolster PPS. I think we all can agree on that.
I should not be the only one that call, everyone invested in ELTP should call and demand an answer over the evaluation. We have the right to know.
I will and i have big ones too :). I already called and ask Dianne many times and they have always dodged it.
The evaluation was done to lure in investors, 70 percent drop in PPS in 6 weeks is the proof. You guys have to stop sugar coating these realities. I hope at the next CC someone has the balls to ask Nasrat about the evaluation and hopefully some light will be shed to put investors at ease.
I am long here but i have to agree with Richme, Fraududent evaluation railraoded many buying into ELTP.
I agree that there has been positive steps in moving this company forward but there is so many uncertainties in this company that is reflected in PPS. Today is a great confirmation of this company with the new deal with Lincoln Financial, but it is one step in the many required to get ART to the market. People like you guys pump this stock regardless of bad or good news. I am a long with upper 6 figures shares yet i remain skeptical. Please call it for what it is and not BS and allow new new investors the opportunities to make the right decision ... the moral thing to do.
Down 75 percent 6 weeks and up 4.5 percent and everyone is jumping for joy. Whats wrong with you people?
Stop blaming MM, they can not be responsible 75 percent drop in 6 weeks.
If ELTP is truly doing what management said, there should not be a problem getting to 4 dollars in 2 years, But again these are the same folks that said they are currently worth 2.10 cents. Investor have to try really hard to ignore the fact PPS is at .30 cents!!!!
I have, its the same spin that she gives everyone else. " we can't released the firm that did the evaluation." We don't know why shares are dropping faster than flies, we are doing everything on schedule,ETC,. It seems like its a ploy to get shareholder not to sell while they themselves shed shares as with many Pump and Dump. Companies with strong Fundamentals don't drop 75 percent in 6 weeks without any bad news.
Investors flock to ELTP after CC in February, The evaluation was the big seller. You think ELTP would climb that high if the evaluation did not come out?
That is what we all hope, unless they are not as confident in themselves as you and i are in them. they might try to hype it up and sell why investors who believe in them lose their shirt.
Once again CEO came out with an evaluation of .40 to 2.75. PPS is now .32. they refused to release evaluation firms name. CFO clearly stated that only in the worst case scenario that the market crashed and ELTP has no money left, only then .40 will materialized. Need i say more ?
There is no possible legal reasons not to release the firms name. If it is a reputable name like they claimed, releasing the name would only boost PPs.
Revenues from sales is irrelevant, we all know that ART is where the money is... If ELTP is traded on revenues, it would be 5 cents PPS.
Nice try Aqua, why don't you explain to me about the evaluation and why they did not released the name of the firm.
They came out with a evaluation of 40 cents to 2.75 and stock plummet to 30 cents, they would not release the name of firm that did the evaluation. I know you guys continue to support this company because you believe the CEO but the truth is they have lied to us.
Its a Scam when Management said its worth 2 dollars and we are at 30 cents.
I agree with your assessment,if we look at the fundamentals ELTP remain solid. But in the last 6 weeks PPs has gone down 60%, I am starting to question these fundamentals that we all believe in. Stock with strong fundamentals do not dropn 60% in 6 weeks. Please tell me you don't have doubts.
BE are done in house, only trials that can be verify independently matters. Look at PPS, someone has unlimited amount of shares to sell. this is starting to stink real bad and you all know it.
They are not bleeding as hard as ELTP 60% in 5 weeks.
Delays in trial is what fear all Longs like me the most, not PPS. The money in ELTP ultimately comes from ART, If there are issues regarding trial.
Delays in trial is what fear all Longs like me the most, not PPS. The money in ELTP ultimately comes from ART, If there are issues regarding trial.
My concern is also with the evaluation, In the last CC, they have said 40 cents was only a doom and gloom scenario and here we are at 36 cents.
You really deny his credentials, i bought in to his confidence that ELTP will have ART in the market this year. With the lack of PR and missed deadline, i am stating to worry.
We all have bought into what NH said, that is why we are all here. So far it has been disappointing.